psoriasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria :Conform to the diagnostic criteria of psoriasis vulgaris with western medicine; Conform to the psoriasis standards of the blood heat syndrome, blood dryness syndrome and blood stasis syndrome; The age is ranging from 18 to 65 years old; The illness severity: the lesion degree is mild-to-moderate (20 >BSA >5). Sign in the informed consent, volunteer to recept the test, The informed consent process comply with the provisions of the GCP.
Exclusion criteria
Exclusion criteria: Joints psoriasis, pustular psoriasis and erythrodermic psoriasis; the women in Pregnancy or during the lactation period, have fertility plan in three months; Take glucocorticoid and/or immunosuppressive drugs and retinoic acid drugs for nearly one month or exterally use the glucocorticoid agents or drugs such as retinoic acid and vitamin D3 derivative preparation in two weeks; With cardiovascular, cerebrovascular, liver, kidney and hematopoietic system disease and other severe primary diseases and psychosis patients allergy to the study drugs; Taking part in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin lesion area and severity index score (PASI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology life quality score, SF-36 Quality of Life Scale;The measure of skin barrier function;The major clinical syndromes of traditional Chinese medicine scoring index;auxiliary examination: Blood routine, urine routine, liver function, renal function, electrocardiogram (ecg);History of illness and treatment Onset, family history, history of treatment, and other diseases and treatmenthistory;allergic history: Drugs, food or contact allergy;TCM symptoms, tongue, pulse condition;vital signs: Body temperature, breathing, heart rate, blood pressure;Demographic indicators; | — |
Countries
China